3D Cine Cardiovascular Magnetic Resonance
Comprehensive Free-breathing 3D Cine Cardiovascular Magnetic Resonance
1 other identifier
observational
51
1 country
1
Brief Summary
Conventional CMR is based on breath-hold 2D cine image acquisitions which are sequentially acquired in different imaging planes. The necessity of precisely planning and then acquiring multiple 2D imaging planes during breath-hold is relatively inefficient and leads to CMR exam times of ≤60 minutes. However, some patients are too ill or young to hold their breath. Furthermore, 2D images sometimes fail to provide a complete picture of complex 3D anatomy of patients with complex morphology. To address these limitations, we have recently developed a 3D cine (3 spatial dimensions plus time) CMR technique. Rather than acquiring 2D cine images in multiple orientations during breath-hold, this approach allows one to acquire a free-breathing 3D block of data for each phase of cardiac cycle that can be reformatted offline into the desired views without adding to the exam time. This added efficiency should lead to a reduction in CMR exam time, increasing patient comfort, and making CMR exam easy and available for all. In addition, the 3D nature of the data may yield more complete information about the anatomy and physiology. In this proposal, we will examine the agreement between the 2D cine and 3D cine CMR techniques with regard to left and right ventricular volumes and systemic and pulmonary blood flow circulation. The internal consistency of the measurements between the 2 techniques will be also investigated. This study will focus on children because they may benefit the most from the short, improved efficiency, and free-breathing CMR exams.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2018
CompletedFirst Posted
Study publicly available on registry
July 11, 2018
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 4, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 4, 2021
CompletedMarch 21, 2022
March 1, 2022
1.8 years
June 27, 2018
March 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
End-diastolic and end-systolic volumes of right and left ventricles
1 day
Study Arms (1)
Patients with congenital heart disease
Patients with congenital heart disease who are greater than 40 kg and are referred for a clinically indicated 2D CMR exam with a gadolinium-based contrast agent.
Interventions
Cardiovascular Magnetic Resonance Imaging or MRI exam from children's with congenital heart disease
Eligibility Criteria
Patients with different races and ethnicity are included in the study.
You may qualify if:
- Patients who are greater than 40 kg and are referred for a clinically indicated 2D CMR exam with a gadolinium-based contrast agent. Informed consent/assent will be obtained.
You may not qualify if:
- Patients who are under anesthesia, sedated, or with a contraindication to CMR exams.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Tarek Alsaied
Cincinnati, Ohio, 45229, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics
Study Record Dates
First Submitted
June 27, 2018
First Posted
July 11, 2018
Study Start
November 1, 2019
Primary Completion
September 4, 2021
Study Completion
October 4, 2021
Last Updated
March 21, 2022
Record last verified: 2022-03